GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Compound class:
Synthetic organic
Comment: GRA2 is reported to act as an inverse agonist of GPR21 [1].
|
|
References |
1. Bordano V, Kinsella GK, Cannito S, Dianzani C, Gigliotti CL, Stephens JC, Monge C, Bocca C, Rosa AC, Miglio G et al.. (2022)
G protein-coupled receptor 21 in macrophages: An in vitro study. Eur J Pharmacol, 926: 175018. [PMID:35537492] |
2. Gardner J, Wu S, Ling L, Danao J, Li Y, Yeh WC, Tian H, Baribault H. (2012)
G-protein-coupled receptor GPR21 knockout mice display improved glucose tolerance and increased insulin response. Biochem Biophys Res Commun, 418 (1): 1-5. [PMID:22155242] |
3. Lin X, Chen B, Wu Y, Han Y, Qi A, Wang J, Yang Z, Wei X, Zhao T, Wu L et al.. (2023)
Cryo-EM structures of orphan GPR21 signaling complexes. Nat Commun, 14 (1): 216. [PMID:36639690] |
4. Osborn O, Oh da Y, McNelis J, Sanchez-Alavez M, Talukdar S, Lu M, Li P, Thiede L, Morinaga H, Kim JJ et al.. (2012)
G protein-coupled receptor 21 deletion improves insulin sensitivity in diet-induced obese mice. J Clin Invest, 122 (7): 2444-53. [PMID:22653059] |
5. Wang J, Pan Z, Baribault H, Chui D, Gundel C, Véniant M. (2016)
GPR21 KO mice demonstrate no resistance to high fat diet induced obesity or improved glucose tolerance. F1000Res, 5: 136. [PMID:27081476] |